Sign in

CIK 0001761918 · <br>Emerging growth company

Erasca, Inc.

Sign in to watch
Ticker
ERAS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831217027
Phone
(858) 465-6511
Business address
3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-07-20 Casdin Alexander W. Director Conversion · Series A Preferred Stock −900,000 0
2021-07-20 ARCH Venture Partners X, LLC 10% owner Conversion +5,527,777 5,527,777
2021-07-20 ARCH Venture Partners X, LLC 10% owner Conversion +5,527,777 5,527,777
2021-07-20 ARCH Venture Partners X, LLC 10% owner Conversion · Series A Preferred Stock −2,100,000 0
2021-07-20 ARCH Venture Partners X, LLC 10% owner Conversion · Series A Preferred Stock −2,100,000 0
2021-07-20 ARCH Venture Partners X, LLC 10% owner Conversion · Series B-1 Preferred Stock −3,400,000 0
2021-07-20 ARCH Venture Partners X, LLC 10% owner Conversion · Series B-2 Preferred Stock −1,133,333 0
2021-07-20 ARCH Venture Partners X, LLC 10% owner Conversion · Series B-1 Preferred Stock −3,400,000 0
2021-07-20 ARCH Venture Partners X, LLC 10% owner Conversion · Series B-2 Preferred Stock −1,133,333 0
2021-07-20 Start Valerie Denise Harding Director Purchase +2,000 $16.00 $32K 2,000
2021-07-20 Multani Pratik S Director Purchase +6,200 $16.00 $99K 172,866
2021-07-20 Hambleton Julie Director Purchase +6,000 $16.00 $96K 6,000

Page 8 of 8 · 152 trades